EDITORIAL We Need to Do Better ERPES ZOSTER (HZ) IS A COMMON, SERI- than 70s or 80s; however, reduction in disease burden ous, and preventable disease. Despite the was 66% in all age groups. In a more recent and larger approval of a safe and effective vaccine population-based study, including more patients with in 2006 for immunocompetent pa- chronic diseases, efficacy of 55% was observed in all age H tients aged 60 years or older, underuse groups. In a recent randomized clinical trial, almost 70% 1,2 of this vaccine remains widespread. Understanding the efficacy in disease prevention was observed in patients in barriers to recommended use and implementation of pro- their 50s. Currently, the vaccine is recommended by the grams to overcome them is critically important in de- Centers for Disease Control and Prevention (CDC) for im- creasing this often devastating disease. Somewhat sur- munocompetent patients aged 60 years and older, includ- prisingly, the most important barrier is lack of a strong ing people with a history of HZ and no known history of physician recommendation for this vaccine. We must do chicken pox; it is also Food and Drug Administration– better so that physicians know about zoster and
JAMA Ophthalmology – American Medical Association
Published: Mar 1, 2013
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera